Our library, the PERC, is a warm, inviting retreat at the Cancer Center
At the University of Michigan Comprehensive Cancer Center’s full service library, the Patient Family Education Resource Center – or PERC – librarians and volunteers are always ready to help. Books, electronic devices (some can be checked out), suggested reading lists and other resources are available to Cancer Center patients, families and caregivers. Not sure what you want? Staff at the PERC can help you figure it out.
Here are just some of the recently purchased books you can find at the PERC: Continue reading →
Medical records and test results are just some of the things the intake coordinators can get from your doctor’s office ahead of your first Cancer Center appointment. Pictured are some of the intake coordinators at the Cancer Center who are here to help. From top left: Amanda Perez, Barbara Ayotte, Christine Fergus, Christine Manners, Christine Nolen, Dianne Hatfield. Row 2: Ileana Chandler, Mary Jane Blaisdell, Nancy Dixson, Rob Bridges, Theresa Jordon.
A cancer diagnosis itself is overwhelming. Usually the next step is to make an appointment with a cancer doctor. But the practical side to making appointments, even second opinion appointments, may seem difficult. The U-M Comprehensive Cancer Center staff understands this and tries to make the appointment process as easy as possible on patients, or on family members helping to arrange the appointment. Intake coordinators smooth the way by assembling all the past medical documentation a new patient has that relates to a cancer diagnosis.
There are 30 different clinics at the Cancer Center which focus on specific cancer types. Each clinic has an intake coordinator who is responsible for obtaining medical information for new patients. This helps to relieve some of the stress new patients and their families may experience leading up to that first appointment with a Cancer Center doctor. Continue reading →
University of Michigan’s Dr. Daniel Orringer with the new SRS microscope which promises to make brain tumor and other cancer surgeries safer and more efficient
Here at the University of Michigan we are testing a new microscope that will radically change brain tumor surgery—making it safer and more efficient. So far, we have used the microscope on tissues from 89 patients with great success.
Timing and location are important
One of the most difficult things for a brain surgeon is figuring out exactly where a brain tumor starts and stops because brain tumor tissue can be hard to distinguish from the rest of the brain. The new stimulated Raman scattering (SRS) microscope allows us to see the edges of a tumor in a few seconds instead of waiting the 30-45 minutes it usually takes for a frozen tumor section to be developed.
Right now, we are using the microscope on an experimental basis through grants from the National Institutes of Health and the University of Michigan Translational Research and Commercialization for Life Sciences Program. We are using the microscope almost exclusively on neurosurgical cases. I’m also collaborating with Matt Spector, who is a head and neck surgeon, to look at squamous cell carcinoma. Continue reading →
Jacqueline Tonks enjoys using technology. At age 78, she’s learned from her grandchildren and children, and is a frequent user of Facebook, Skype and texting. So when she heard about a mobile app that could help her manage her breast cancer treatment, she downloaded it.
“The nice thing about this app is that when I turn on my iPhone or iPad, the app appears and reminds me of things to do today. I really like the reminders of what exercises I’m supposed to do, in what order, and how many. It keeps me on track,” Tonks says. Continue reading →
mCancerPartner interviewed Dan Hayes, M.D., clinical director of the Cancer Center’s breast oncology program. In late September 2015, investigators – including Dr. Hayes – showed that many women with early stage breast cancer can skip chemotherapy with good results, based on a gene test assessing which tumors were more likely to respond to chemotherapy. This study validates clinical recommendations in place since 2007 made by the American Society of Clinical Oncology and the National Comprehensive Cancer Network. Dr. Hayes served on both recommendation task forces and provided the following remarks on the origin of these recommendations.
mCancerPartner: How has the standard of care for women with the most common type of breast cancer (early stage, hormone positive, HER2 negative, not spread to lymph nodes) evolved over the years? Continue reading →
NOTICE: Except where otherwise noted, all articles are published under a Creative Commons Attribution 3.0 license. You are free to copy, distribute, adapt, transmit, or make commercial use of this work as long as you attribute the University of Michigan Health System as the original creator and include a link to this article.